Richard Burr: “Mr. Arny and Mr. Calcara, is there an associated estimate of the costs for this activity?”

What does it mean for a small company when FDA misses these goals, and what does it mean to patients?

More than 278 therapies have been approved under the accelerated approval pathway over the 30 year history, saving and improving thousands of lives.

I was surprised and frustrated to hear that these funds were overwhelmingly repurposed from within ASPR, including the stockpile.

He is an embarrassment on any day that ends in Y.